Trademark Overview
On Friday, January 13, 2023, a trademark application was filed for VELOXIS with the United States Patent and Trademark Office. The USPTO has given the VELOXIS trademark a serial number of 97753205. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, October 11, 2023. This trademark is owned by Veloxis Pharmaceuticals, Inc.. The VELOXIS trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields
Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified release systems, and pharmaceutical controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of physical disorders, emergencies and traumas, burns, diseases of the heart and blood vessels, neurological diseases, and cancer
Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals
Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries